0000912282-26-000629.txt : 20260420
0000912282-26-000629.hdr.sgml : 20260420
20260420153256
ACCESSION NUMBER: 0000912282-26-000629
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260420
DATE AS OF CHANGE: 20260420
EFFECTIVENESS DATE: 20260420
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TelyRx Finco Inc.
CENTRAL INDEX KEY: 0002125491
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-581152
FILM NUMBER: 26874860
BUSINESS ADDRESS:
ADDRESS IS A NON US LOCATION: YES
STREET 1: 333 BAY STREET, SUITE 2400
CITY: TORONTO
PROVINCE COUNTRY: A6
ZIP: M5H 2T6
BUSINESS PHONE: (800) 878-1660
MAIL ADDRESS:
ADDRESS IS A NON US LOCATION: YES
STREET 1: 333 BAY STREET, SUITE 2400
CITY: TORONTO
PROVINCE COUNTRY: A6
ZIP: M5H 2T6
D
1
primary_doc.xml
X0708
D
LIVE
0002125491
TelyRx Finco Inc.
333 Bay Street, Suite 2400
Toronto
A6
ONTARIO, CANADA
M5H 2T6
800-878-1660
ONTARIO, CANADA
None
None
Corporation
true
2026
Vanessa
Slowey
333 Bay Street, Suite 2400
Toronto
A6
ONTARIO, CANADA
M5H 2T6
Director
Executive Officer
John
Eric
Cascio
333 Bay Street, Suite 2400
Toronto
A6
ONTARIO, CANADA
M5H 2T6
Executive Officer
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2026-03-26
false
true
true
Subscription receipts exchangeable for common shares without further consideration upon satisfaction of certain conditions.
false
0
Canaccord Genuity Corp.
None
Canaccord Genuity LLC
000001020
One Pennsylvania Plana Suite 2900
New York
NY
NEW YORK
10119
NY
NEW YORK
12623935
12623935
0
false
51
393732
true
0
C$1.3694=US$1.00
0
false
TelyRx Finco Inc.
/s/ John Cascio
John Cascio
Chief Financial Officer
2026-04-20